ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2016

Expression IRF/MUM1>25% Predictor to Three-year Survival of Diffuse Large B Cell Lymphoma in the Immunochemotherapy Era.

Alma Sofo-Hafizovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.